The anesthetic method has the potential to allow physicians to keep injuries from evolving into neuropathic pain, a chronic form of pain that arises from flawed signals transmitted to damaged nerves.
The team combined saxitoxin, a powerful local anesthetic, with dexamethasone to prolong saxitoxin’s effects. The two ingredients contain liposomes for nontoxic delivery to the site of nerve or tissue damage.
More Articles on Anesthesia:
Somnia Anesthesia to Offer Webinar on Anesthesia Career Trends
Physician Lawmakers Concerned by Policy to Allow Patients to Report Medical Mistakes
Personally Performed Anesthesia Payments to be Reviewed by Office of Inspector General
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
